Skip Nav Destination

Oncology

Find more information about this subject area.

Latest Content

Research Article

Incorporating ALBI Grade with Geriatric Nutritional Risk Index Enhances Hepatocellular Carcinoma Risk Stratification

Heechul Nam; Pil Soo Sung; Sung Won Lee; Do Seon Song; Jung Hyun Kwon; Jeong Won Jang; Chang Wook Kim; Si Hyun Bae

https://doi.org/10.1159/000541647

Research Article

Long-term outcome of a multicenter prospective study on efficacy and safety of high-dose Stereotactic Body Radiation Therapy ≥ 48 hour-interfraction interval for ≤ 5 cm hepatocellular carcinoma

Jin-Kyu Kang; Mi-Sook Kim; Won Il Jang; Chul Ju Han; Jin Kim; Su Cheol Park; Young-Joo Shin; Chul Won Choi; Wan Jeon; Tosol Yu; Ah Ram Chang; Hae Jin Park; Younghee Park; Eun Seog Kim; Sunmi Jo; Woo Chul Kim; Hun Jung Kim; Sun Hyun Bae; Eunji Kim

https://doi.org/10.1159/000541685

Research Article

The impact of radiation dose and tumour burden on outcomes in hepatocellular carcinoma: 11-year experience in a 413-patient cohort treated with yttrium-90 resin microsphere radioembolisation

Kaina Chen; Aaron K.T. Tong; Fiona N.N. Moe; David C.E. Ng; Richard H.G. Lo; Apoorva Gogna; Sean X. Yan; Sue Ping Thang; Kelvin S.H. Loke; Nanda Karaddi Venkatanarasimha; Hian Liang Huang; Chow Wei Too; Timothy S.K. Ong; Eng Xuan Yeo; Daniel Yang Yao Peh; Ashley W.Y. Ng; Lu Yang; Wan Ying Chan; Jason P.E. Chang; Brian K.P. Goh; Han Chong Toh; Pierce K.H. Chow

https://doi.org/10.1159/000541539

Research Article

Depth of radiographic response as an independent prognostic factor for patients with initially unresectable hepatocellular carcinoma receiving hepatectomy following targeted therapy plus immunotherapy

Bin Xu; Lu-Na Wang; Zi-Yi Wang; Tian He; Xiao-Dong Zhu; Ying-Hao Shen; Jian Zhou; Jia Fan; Hui-Chuan Sun; Cheng Huang

https://doi.org/10.1159/000541300

Guidelines

Consensus of Chinese expert on neoadjuvant and conversion therapies for hepatocellular carcinoma: 2023 update

Xinyu Bi; Haitao Zhao; Hong Zhao; Guangming Li; Xiaodong Wang; Bo Chen; Wen Zhang; Xu Che; Zhen Huang; Yue Han; Liming Jiang; Yongkun Sun; Zhengqiang Yang; Jianguo Zhou; Yefan Zhang; Zhenyu Zhu; Minshan Chen; Shuqun Cheng; Jianqiang Cai

https://doi.org/10.1159/000541249

Research Article

Dynamic Peripheral T-Cell Analysis Identifies On-Treatment Prognostic Biomarkers of Atezolizumab plus Bevacizumab in Hepatocellular Carcinoma

Ji Won Han; Min Woo Kang; Soon Kyu Lee; Hyun Yang; Ji Hoon Kim; Jae-Sung Yoo; Hee Sun Cho; Eun Ji Jang; Deok Hwa Seo; Jung Hyun Kwon; Soon Woo Nam; Si Hyun Bae; Jeong Won Jang; Jong Young Choi; Seung Kew Yoon; Pil Soo Sung

https://doi.org/10.1159/000541181

Systematic Review

Particle Therapy for Intrahepatic Cholangiocarcinoma: A Multicenter Prospective Registry Study, Systematic Review and Meta-Analysis

Masashi Mizumoto; Kei Shibuya; Kazuki Terashima; Masao Murakami; Motohiro Murakami; Yoshiyuki Shioyama; Yoshiro Matsuo; Takashi Ogino; Tatsuya Ohno; Takahiro Waki; Hiroyuki Ogino; Hiroyasu Tamamura; Norio Katoh; Masaru Wakatsuki; Tomoaki Okimoto; Motohisa Suzuki; Takashi Saito; Shingo Toyama; Takayuki Hashimoto; Hisateru Ohba; Shoji Kubo; Kiyoshi Hasegawa; Kazushi Maruo; Hideyuki Sakurai

https://doi.org/10.1159/000540291

Review Article

The Impact of Normal Hepatobiliary Cell Zonation Programs on the Phenotypes and Functions of Primary Liver Tumors

Tomoko Aoki; Naoshi Nishida; Yasunori Minami; Masatoshi Kudo

https://doi.org/10.1159/000541077

Research Article

Impact of Diabetes Mellitus and Obesity Comorbidities on Survival Outcomes after Hepatocellular Carcinoma Resection: A Multicenter Retrospective Study

Hiroji Shinkawa; Masaki Kaibori; Masaki Ueno; Satoshi Yasuda; Hisashi Ikoma; Tsukasa Aihara; Takuya Nakai; Masahiko Kinoshita; Hisashi Kosaka; Shinya Hayami; Yasuko Matsuo; Ryo Morimura; Takayoshi Nakajima; Chihoko Nobori; Takeaki Ishizawa

https://doi.org/10.1159/000540858

Research Article

Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries

Choong-kun Lee; Changhoon Yoo; Jung Yong Hong; Se Jun Park; Jin Won Kim; David Wai Meng Tai; Hyeyeong Kim; Krittiya Korphaisarn; Suebpong Tanasanvimon; San-Chi Chen; Ju Won Kim; Ilhwan Kim; Moonho Kim; Joan Choo; Sang-Bo Oh; Ching-Tso Chen; Woo Kyun Bae; Hongsik Kim; Seok Jae Huh; Chia-Jui Yen; Sejung Park; Dong Ki Lee; Landon Long Chan; Beodeul Kang; Minsu Kang; Raghav Sundar; Hye Jin Choi; Stephen Lam Chan; Hong Jae Chon; Myung-Ah Lee

https://doi.org/10.1159/000540969

Research Article

I-Cheng Lee; Hao-Jan Lei; Lei-Chi Wang; Yi-Chen Yeh; Gar-Yang Chau; Cheng-Yuan Hsia; Shu-Cheng Chou; Jiing-Chyuan Luo; Ming-Chih Hou; Yi-Hsiang Huang

https://doi.org/10.1159/000540802

Research Article

The Impact of TP53-Induced Glycolysis and Apoptosis Regulator on Prognosis in Hepatocellular Carcinoma: Association with Tumor Microenvironment and Ferroptosis

Katsuya Toshida; Shinji Itoh; Norifumi Iseda; Shugo Tanaka; Kensuke Nakazono; Takahiro Tomiyama; Shohei Yoshiya; Takeo Toshima; Noboru Harada; Kenichi Kohashi; Koji Taniguchi; Yoshinao Oda; Tomoharu Yoshizumi

https://doi.org/10.1159/000540180

Editorial

Nivolumab plus Ipilimumab: A Novel First-Line Combination Immunotherapy for Unresectable Hepatocellular Carcinoma

Masatoshi Kudo

https://doi.org/10.1159/000540801

Research Article

Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without Mammalian Target of Rapamycin Inhibitors in Patients with Fibrolamellar Carcinoma

Ghassan K. Abou-Alfa; Tim Meyer; Richard Kinh Gian Do; Sarina A. Piha-Paul; Joseph S. Light; Scott Sherrin; Amin Yaqubie; Alison Clemens O’Neill; James J. Harding; Raed Al-Rajabi; Crystal S. Denlinger; Pablo Cano; Albert S. Cornelius; Eileen M. O'Reilly; Daniel DiPrimeo; Lisa D. Eli; John D. Gordan; David B. Solit

https://doi.org/10.1159/000540290

Erratum

Erratum - Characterization of Tumor Responses in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in the Phase 3 Randomized Trial: REFLECT

https://doi.org/10.1159/000540463

Research Article

Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Hepatocellular Carcinoma with Main Trunk and/or Contralateral Portal Vein Invasion in IMbrave150

Richard S. Finn; Peter R. Galle; Michel Ducreux; Ann-Lii Cheng; Norelle Reilly; Alan Nicholas; Sairy Hernandez; Ning Ma; Philippe Merle; Riad Salem; Daneng Li; Valeriy Breder

https://doi.org/10.1159/000539897

Research Article

Plasma Adiponectin Levels in Relation to Chronic Hepatitis B Infection Progression to Liver Cancer Milestones: A Prospective Study

Chi-Ling Chen; Wei-Shiung Yang; Hwai-I. Yang; Chuen-Fei Chen; Li-Yu Wang; Sheng-Nan Lu; Jia-Horng Kao; Pei-Jer Chen; Chien-Jen Chen

https://doi.org/10.1159/000539909

Research Article

Cost-Effectiveness of a Biomarker-Based Screening Strategy for Hepatocellular Carcinoma in Patients with Cirrhosis

Amit G. Singal; Jagpreet Chhatwal; Neehar Parikh; Elliot Tapper

https://doi.org/10.1159/000539895

Research Article

Prognostic Efficacy of the Albumin-Bilirubin Score and Treatment Outcomes in Hepatocellular Carcinoma: A Large-Scale, Multi-Center Real-World Database Study

Kyu-Pyo Kim; Kang Mo Kim; Baek-Yeol Ryoo; Won-Mook Choi; Won Chul Cha; Mira Kang; Dong Hyun Sinn; Myung Ji Goh; Do Young Kim; Min Ji Lee; Subin Lim; DongKyu Kim; Kyoungdae Baek; Joohyun Kim; Eui Jun Choi; Doik Lee; Jung-Ae Kim; Ki-Hun Kim

https://doi.org/10.1159/000539724

Research Article

LI-RADS Category Can Be a Post-Surgical Prognostic Factor for Intrahepatic Cholangiocarcinoma in Patients with Liver Cirrhosis or Chronic Hepatitis B

Sungeun Park; Boyeon Koo; Boryeong Jeong; Sang Hyun Choi; Jeong Min Lee

https://doi.org/10.1159/000539794

1 2 3 4 5

Oncology

Latest Content

INFORMATION

ABOUT US

SERVICES FOR

Karger International

Oncology

Latest Content

This Feature Is Available To Subscribers Only